# Evaluation of [¹⁸F]MODAG-009 PET Imaging in Synucleinopathies

> **NCT07640555** · EARLY_PHASE1 · RECRUITING · sponsor: **MODAG GmbH** · enrollment: 13 (estimated)

## Conditions studied

- Multiple System Atrophy (MSA)
- Healthy Adult
- Parkinson Disease

## Interventions

- **DRUG:** [¹⁸F]MODAG-009 PET imaging

## Key facts

- **NCT ID:** NCT07640555
- **Lead sponsor:** MODAG GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-13
- **Primary completion:** 2027-05
- **Final completion:** 2027-05
- **Target enrollment:** 13 (ESTIMATED)
- **Last updated:** 2026-06-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07640555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07640555, "Evaluation of [¹⁸F]MODAG-009 PET Imaging in Synucleinopathies". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07640555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*